Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Editas Medicine, Inc. publishes a filing, an earnings call transcript or a press release.

Get EDIT alerts

About Jim Mullen

Jim Mullen is recorded as CEO at Editas Medicine, Inc. (EDIT). Jim Mullen has spoken on 4 earnings calls across 1 company, most recently for Editas Medicine, Inc. on August 3, 2022. Editas Medicine, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Editas Medicine, Inc. includes Gilmore O'Neill, M.B., M.M.Sc. (CEO and Board Member), James C. Mullen (CEO), Katrine S. Bosley (CEO) and 7 others.

Jim Mullen on recent calls

“I am joined today by several members of the Editas executive team, including Gilmore O’Neill, our Chief Executive Officer; Mark Shearman, our Chief Scientific Officer; Michelle Robertson, our Chief Financial Officer; and Baisong Mei, who I’m thrilled to welcome as our new Chief Medical Officer.”
Chairman, Editas Medicine, Inc. Q2 FY2022 Earnings Call ·
“I am joined today by several members of the Editas executive team, including Mark Shearman, our Chief Scientific Officer; Michelle Robertson, our Chief Financial Officer, and Charlene Stern, our General Counsel.”
CEO, Editas Medicine, Inc. Q1 FY2022 Earnings Call ·
“I am joined today by several members of the Editas executive team, including Mark Shearman, our Chief Scientific Officer and Michelle Robertson, our Chief Financial Officer.”
CEO, Editas Medicine, Inc. Q4 FY2021 Earnings Call ·
“In addition to Ron, I’m joined by Lisa Michaels, our Chief Medical Officer; and Michelle Robertson, our Chief Financial Officer. I will start with providing some highlights from the first quarter reviewing our broader corporate strategy.”
CEO, Editas Medicine, Inc. Q1 FY2021 Earnings Call ·

Affiliation history

Company network

Leadership on record at Editas Medicine, Inc.

Recent activity